Cargando…
Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation
DNA vaccines are stable, safe, and cost effective to produce and relatively quick and easy to manufacture. However, to date, DNA vaccines have shown relatively poor immunogenicity in humans despite promising preclinical results. Consequently, a number of different approaches have been investigated t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632145/ https://www.ncbi.nlm.nih.gov/pubmed/31200559 http://dx.doi.org/10.3390/vaccines7020050 |